Takafumi Kadono

Serum concentrations of basic fibroblast growth factor in collagen diseases.

M. Fujimoto, T. Kadono, K. Tamaki, 1996, Journal of the American Academy of Dermatology.

Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study

T. Miyagawa, Takafumi Kadono, Yasuhiro Fujisawa, 2014, The British journal of dermatology.

Clinical significance of serum retinol binding protein‐4 levels in patients with systemic sclerosis

Y. Tada, Y. Asano, M. Sugaya, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis

Y. Tada, Y. Asano, M. Sugaya, 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

BAFF levels are increased in lesional skin and sera in patients with cutaneous T‐cell lymphoma

Y. Tada, Y. Asano, M. Sugaya, 2012, The British journal of dermatology.

Tissue inhibitor of metalloproteinase 1 (TIMP-1) may be an autocrine growth factor in scleroderma fibroblasts.

M. Furue, T. Kadono, K. Tamaki, 1997, The Journal of investigative dermatology.

A possible contribution of lipocalin‐2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis

Y. Tada, Y. Asano, M. Sugaya, 2015, The British journal of dermatology.

Decreased ET(B) receptor expression in human metastatic melanoma cells.

M. Mihm, T. Kadono, H. Byers, 1996, Biochemical and biophysical research communications.

Serum lipocalin‐2 levels are increased in patients with psoriasis

S. Watanabe, Y. Tada, Y. Asano, 2012, Clinical and experimental dermatology.